Lysergic Acid Diethylamide

DRUG6 trials

Sponsors

University Hospital, Basel, Switzerland, University of Chicago, University of Fribourg

Conditions

Cluster HeadacheHealthy

Phase 1

Mood Effects of Serotonin Agonists

CompletedNCT03790358

University of ChicagoHealthy

Start: 2018-05-01End: 2023-01-27Updated: 2024-01-24

Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects

CompletedNCT04516902

University Hospital, Basel, SwitzerlandHealthy

Start: 2021-01-01End: 2022-08-22Updated: 2022-08-23

Effect of Ketanserin After LSD Administration

CompletedNCT04558294

University Hospital, Basel, SwitzerlandHealthy

Start: 2020-10-16End: 2021-09-29Updated: 2021-10-21

Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects

CompletedNCT05175430

University Hospital, Basel, SwitzerlandHealthy

Start: 2022-10-24End: 2024-03-07Updated: 2024-03-13

Effects of LSD on Neuroplasticity in Healthy Subjects

CompletedNCT05177419

University of FribourgHealthy

Start: 2022-05-02End: 2025-03-12Updated: 2025-04-06

Phase 2

Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache

RecruitingNCT03781128

University Hospital, Basel, SwitzerlandCluster Headache

Start: 2019-01-02End: 2025-12-31Target: 30Updated: 2025-02-07

Related Papers

Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.

2023-05-3122 citations

Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants

The International Journal of Neuropsychopharmacology2022-11-0487 citations